Top

Archives of Gynecology and Obstetrics

Published in:

01-11-2011 | Materno-fetal Medicine

Macrosomia prediction using different maternal and fetal parameters in women with 50 g glucose challenge test between 130 and 140 mg/dl

Authors: Ebru Tarim, Tayfun Cok

Published in: Archives of Gynecology and Obstetrics | Issue 5/2011

Abstract

Objective

Our aim in this study was to investigate the association between 1-h glucose challenge test (GCT) of 130–140 mg/dl and the development of macrosomia.

Methods

In this retrospective cohort study, patients with GCT between 130 and 140 mg/dl were divided into two groups. Macrosomic and appropriate-for-gestational-age (AGA) term neonates were compared for the presence of maternal risk factors and fetal abdominal circumference between 29 and 34 weeks.

Results

There were no significant differences between the groups with respect to maternal age, parity, BMI at the first trimester and at the time of GCT, gestational weeks at delivery. However; history of a macrosomic baby delivery was significantly higher in macrosomic group (33.3% for group 1, 11.3% for group 2, p = 0.001).

Abdominal circumference at 29–34 weeks of gestations was significantly higher in macrosomic group (32.46 ± 1.97 for group 1 vs. 31.06 ± 2.46 for group 2, p = 0.002).

Conclusion

History of a macrosomic baby delivery and abdominal measurement at 29–34 weeks was important predictors of macrosomia in patients with GCT between 130 and 140 mg/dl.

American Diabetes Association (2001) Gestational diabetes mellitus. Diabetes Care 24(Suppl 1):S77–S79

Coustan DR (2000) Making the diagnosis of gestational diabetes mellitus. Clin Obstet Gynecol 43:99–105PubMedCrossRef

Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS (2005) The Australian Carbohydrate intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486PubMedCrossRef

Spellacy W, Miller S, Winegar A, Peterson P (1985) Macrosomia: maternal characteristics and infant complications. Obstet Gynecol 66:158–161PubMed

Vohr B, McGarvey S (1997) Growth patterns of large-for-gestational-age and appropriate for-gestational-age infants of gestational diabetes mothers and control mothers at 1 year. Diabetes Care 20:1066–1072PubMedCrossRef

Dabelea D, Pettitt D, Hanson R, Imperatore G, Bennett P, Knowler W (1999) Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care 22:944–950PubMedCrossRef

Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21(Suppl 2):B161–B167PubMed

American College of Obstetricians and Gynecologists (1994) Diabetes and pregnancy. Technical Bulletin No. 200, December 1994

Yalcin HR, Zorlu CG (1996) Threshold value of glucose screening tests in pregnancy: could it be standardized for every population? Am J Perinatol 13:317–320PubMedCrossRef

10.

Vitoratos N, Salamalekis E, Bettas P, Kalabokis D, Chrisikopoulos A (1997) Which is the threshold glucose value for further investigation in pregnancy? Clin Exp Obstet Gynecol 24:171–173PubMed

11.

Rey E, Monier D, Lemonnier MC (1996) Carbohydrate intolerance in pregnancy: incidence and neonatal outcomes. Clin Invest Med 19:406–415PubMed

12.

Okun N, Verma A, Mitchell BF, Flowerdew G (1997) Relative importance of maternal constitutional factors and glucose intolerance of pregnancy in the development of newborn macrosomia. J Matern Fetal Med 6:285–290PubMedCrossRef

13.

Verma A, Mitchell BF, Demianczuk N, Flowerdew G, Okun N (1997) Relationship between plasma glucose levels in glucose-intolerant women and newborn macrosomia. J Matern Fetal Med 6:187–193PubMedCrossRef

14.

Tan YY, Yeo GS (1996) Impaired glucose tolerance in pregnancy\Mis it of consequence? Austr N Z J Obstet Gynaecol 36:248–255CrossRef

15.

Aparicio NJ, Joao MA, Cortelezzi M, Guz M, Sturgeon C, Galimberti DM et al (1998) Pregnant women with impaired tolerance to an oral glucose load in the afternoon: evidence suggesting that they behave metabolically as patients with gestational diabetes. Am J Obstet Gynecol 178:1059–1066PubMedCrossRef

16.

Roach VJ, Hin LY, Tam WH, Ng KB, Rogers MS (2000) The incidence of pregnancy-induced hypertension among patients with carbohydrate intolerance. Hypertens Pregnancy 19:18–19CrossRef

17.

Jensen DM, Damm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Klebe J et al (2001) Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 185:413–419PubMedCrossRef

18.

Aberg A, Rydhstroem H, Frid A (2001) Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 184:77–83PubMedCrossRef

19.

Kahn K, Hashmi FA, Rizvi JH (1995) Are non-diabetic women with abnormal glucose screening test at increased risk of pre-eclampsia, macrosomia and cesarean birth? J Pak Med Assoc 45:176–179

20.

Bochner CJ, Medearis AL, Williams J, Castro L, Hobel CJ, Wade ME (1987) Early third trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 157:703–708PubMed

21.

Landon MB, Mintz MC, Gabbe SG (1989) Sonographic evaluation of fetal abdominal growth: predictor of large-for-gestational age infant in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 160:115–121PubMed

22.

Hadlock FP, Harrist RB, Carpenter RJ, Deter RL, Park SK (1984) Sonographic estimation of fetal weight. Radiology 150:535–540PubMed

23.

Hadlock FP, Harrist RB, Sharman RS, Deter RL, Rossavik UK (1985) Estimation of fetal weight with the use of head, body, and femur measurements: a prospective study. Am J Obstet Gynecol 151:333–337PubMed

24.

Carpenter MW, Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768–773PubMed

25.

Cheng YW, Block-Kurbisch I, Caughey AB (2009) Obstet Gynecol 114:326–332. Carpenter-Coustan criteria compared with the national diabetes data group thresholds for gestational diabetes mellitus. Comment in: Obstet Gynecol 2009;114:1376 (author reply 1376–1377)

26.

Langer O, Anyaegbunam A, Brustman L, Divon M (1989) Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 161(3):593–599PubMed

27.

WHO (1980) Expert committee on diabetes mellitus: second report. World Health Organ Tech Rep Ser 646:1–80

28.

Gillmer MD, Beard RW, Brooke FM, Oakley NW (1975) Carbohydrate metabolism in pregnancy. Part I. Diurnal plasma glucose profile in normal and diabetic women. Br Med J 3(5980):399–402PubMedCrossRef

29.

(1975) Carbohydrate metabolism in pregnancy. Part II. Relation between maternal glucose tolerance and glucose metabolism in the newborn. Br Med J 3(5980):402–404

30.

Greenberg LR, Moore TR, Murphy H (1995) Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 86(1):97–101PubMedCrossRef

31.

Gaudier FL, Hauth JC, Poist M, Corbett D, Cliver SP (1992) Recurrence of gestational diabetes mellitus. Obstet Gynecol 80(5):755–758PubMed

32.

O’Sullivan JB, Mahan CM, Charles D, Dandrow RV (1973) Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 116(7):895–900PubMed

33.

Ayach W, Costa RA, Calderon Ide M, Rudge MV (2006) Comparison between 100-g glucose tolerance test and two other screening tests for gestational diabetes: combined fasting glucose with risk factors and 50-g glucose tolerance test. Sao Paulo Med J 124(1):4–9PubMedCrossRef

34.

Biri A, Korucuoglu U, Ozcan P, Aksakal N, Turan O, Hımmetoglu O (2009) Effect of different degrees of glucose intolerance on maternal and perinatal outcomes. J Matern Fetal Neonat Med 22(6):473–478CrossRef

35.

Pedersen J (1977) The pregnant diabetic and her newborn, 2nd edn. Williams & Wilkins, Baltimore

36.

Weiss PA, Kainer F, Haas J (1998) Cord blood insulin to assess the quality of treatment in diabetic pregnancies. Early Hum Dev 51:187–195PubMedCrossRef

37.

Rudge MV, Lima CA, Paulette TA, Jovanovic L, Negrato CA, Rudge CV, Calderon IM, Dias A, Atallah AN (2008) Influence of lower cutoff values for 100-g oral glucose tolerance test and glycemic profile for identification of pregnant women at excessive fetal growth risk. Endocr Pract 14(6):678–685PubMed

38.

Rudge MV, Peraçoli JC, Berezowski AT, Calderon IM, Brasil MA (1990) The oral glucose tolerance test is a poor predictor of hyperglycemia during pregnancy. Braz J Med Biol Res 23(11):1079–1089PubMed

39.

Pedula KL, Hillier TA, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ (2009) Ethnic differences in gestational oral glucose screening in a large US population. Ethn Dis 19:414–419PubMed

40.

Silva JK, Kaholokula JK, Ratner R, Mau M (2006) Ethnic differences in perinatal outcome of gestational diabetes mellitus. Diabetes Care 29:2058–2063PubMedCrossRef

41.

Metzger BE (2002) The hyperglycemia and adverse pregnancy outcome (HAPO) study. Int J Gynaecol Obstet 78:69–77CrossRef

42.

Pressman EK, Bienstock JL, Blakemore KJ, Martin SA, Callan NA (2000) Prediction of birth weight by ultrasound in the third trimester. Obstet Gynecol 95:502–506PubMedCrossRef

43.

Ben-Haroush A, Yogev Y, Hod M (2004) Fetal weight estimation in diabetic pregnancies and suspected fetal macrosomia. J Perinat Med 32:113–121PubMedCrossRef

Title: Macrosomia prediction using different maternal and fetal parameters in women with 50 g glucose challenge test between 130 and 140 mg/dl
Authors: Ebru Tarim
Tayfun Cok
Publication date: 01-11-2011
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 5/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-010-1797-2

At a glance: The STEP trials

Springer Medicine

Macrosomia prediction using different maternal and fetal parameters in women with 50 g glucose challenge test between 130 and 140 mg/dl

Abstract

Objective

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2011

Pregnancy complicating systemic lupus erythematosus: a series of 86 cases

Expect the unexpected: primary breast MALT lymphoma

Laparoscopic ovarian diathermy after clomiphene failure in polycystic ovary syndrome: is it worthwhile? A randomized controlled trial

Iatrogenic transtubal spill of endometrial cancer: risk or myth

Human papillomavirus infection in pregnant women

Pregnancy outcome and fertility after complete uterine rupture: a report of 20 pregnancies and a review of literature